Department of Radiology, Neurointervention Clinic, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Neurointervention, GangNam St. Peter's Hospital, Seoul, Korea.
Korean J Radiol. 2022 Aug;23(8):828-834. doi: 10.3348/kjr.2021.0940. Epub 2022 Jun 20.
This study aimed to assess the outcomes of outpatient day-care management of unruptured intracranial aneurysm (UIA), and to present the risks associated with different management strategies by comparing the outcomes and adverse events between outpatient day-care management and management with longer admission periods.
This retrospective cohort study used prospectively registered data and was approved by a local institutional review board. We enrolled 956 UIAs from 811 consecutive patients (mean age ± standard deviation, 57 ± 10.7 years; male:female = 247:564) from 2017 to 2020. We compared the outcomes after embolization among the different admission-length groups (1, 2, and ≥ 3 days). The outcomes included pre- and post-modified Rankin Scale (mRS) scores and rates of adverse events, cure, recurrence, and reprocedure. Events were defined as any cerebrovascular problems, including minor and major stroke, death, or hemorrhage.
The mean admission period was 2 days, and 175 patients (191 aneurysms), 551 patients (664 aneurysms), and 85 patients (101 aneurysms) were discharged on the day of the procedure, day 2, and day 3 or later, respectively. During the mean 17-month follow-up period (range 6-53 months; 2757 patient years), no change in post-mRS was observed compared to pre-mRS in 99.6% of patients. Cure was achieved in 95.6% patients; minimal recurrence that did not require re-procedure occurred in 3.5% patients, and re-procedure was required in 2.3% (22 of 956) patients due to progressive enlargement of the recurrent sac during follow up (mean 17 months, range, 6-53 months). There were eight adverse events (0.8%), including five cerebrovascular (two major stroke, two minor strokes and one transient ischemic stroke), and three non-cerebrovascular events. Statistical comparison between groups with different admission lengths (1, 2, and ≥ 3 days) revealed no difference in the outcomes.
This study revealed no difference in outcomes and adverse events according to the admission period, and suggested that UIA could be managed by outpatient day-care embolization.
本研究旨在评估未破裂颅内动脉瘤(UIA)门诊日间护理管理的结果,并通过比较门诊日间护理管理与住院时间较长的管理策略的结果和不良事件,来呈现不同管理策略相关的风险。
本回顾性队列研究使用前瞻性注册数据,得到了当地机构审查委员会的批准。我们纳入了 2017 年至 2020 年间 811 例连续患者中的 956 例 UIA(平均年龄±标准差,57±10.7 岁;男性:女性=247:564)。我们比较了不同住院时长(1、2 和≥3 天)组之间栓塞后的结果。结果包括改良 Rankin 量表(mRS)评分的术前和术后变化,以及不良事件、治愈、复发和再次治疗的发生率。事件定义为任何脑血管问题,包括小卒中和大卒中等死亡或出血。
平均住院时间为 2 天,分别有 175 例(191 个动脉瘤)、551 例(664 个动脉瘤)和 85 例(101 个动脉瘤)在手术当天、第 2 天和第 3 天或更晚出院。在平均 17 个月的随访期(范围 6-53 个月;2757 患者年)内,99.6%的患者术后 mRS 无变化。95.6%的患者达到治愈;3.5%的患者出现微小复发但无需再次治疗,2.3%(956 例中的 22 例)的患者因随访期间(平均 17 个月,范围 6-53 个月)复发囊的进展而需要再次治疗。共有 8 例不良事件(0.8%),包括 5 例脑血管事件(2 例大卒中和 2 例小卒中和 1 例短暂性脑缺血发作)和 3 例非脑血管事件。对住院时间不同(1、2 和≥3 天)的组进行统计学比较,结果无差异。
本研究表明,住院时间的不同与结果和不良事件无差异,提示 UIA 可以通过门诊日间栓塞治疗进行管理。